Law Office of Philip P. Crowley LLC
Schedule a complimentary consultation:

Implications of SCOTUS inter partes review ruling on biologics

One recent decision by the U.S. Supreme Court might have escaped the notice of many in the country. We doubt that entrepreneurs in New Jersey and elsewhere missed the news, however, considering the potential scope of the ruling across all areas of industry, including life sciences.

The case was Oil States Energy Services, LC, v Greene's Energy Group, LLC. The issue was whether inter partes review (IPR), an administrative process instituted by the U.S. Patent and Trademark Office to deal with challenges to patents, violates the Constitutional guarantees due process in the courts against a taking by the government.

In a 7-2 ruling, the court said the IPR system is OK and went further by explaining that patents, rather than being property owned by holders, are public rights granted by the government. In that context, the justices said, the USPTO's use of IPR is a legitimate exercise of its rights-granting authority.

While the decision specifically addressed questions related to patents covering devices and methods used in hydraulic fracturing for petroleum extraction, legal observers say the implications are far broader than that. Nearly all industries stand to be affected, including the fields of biologic and biosimilar pharmaceuticals. Analysts note that developers of biosimilar drugs regularly rely on IPR as a means to challenge the validity of patents granted for biologic drugs.

With the decision, biosimilar drug makers are assured of being able to continue using the IPR process, which offers the potential for faster and less costly adjudication of patent challenges than going through the courts.

The legal matters associated with any new or existing business endeavor create unique challenges. To anticipate and avoid issues, or deal with disputes when they arise, it's important to work with an attorney who understands nuances of monetizing science and technology.

No Comments

Leave a comment
Comment Information

Get a complimentary consultation

Bold labels are required.

Contact Information

The use of the Internet or this form for communication with the firm or any individual member of the firm does not establish an attorney-client relationship. Confidential or time-sensitive information should not be sent through this form.


Privacy Policy

Morristown Office
89 Headquarters Plaza
North Tower #1461
Morristown, NJ 07960

Phone: 908-336-0795
Fax: 908-325-0217
Morristown Law Office Map

New York Office
800 Third Avenue
28th Floor
New York, NY 10022

Phone: 908-336-0795
Fax: 908-325-0217
New York Law Office Map